10x Genomics
TXG
$27.23
Share price
-1.27%
Change (1 day)
-49.82%
Change (1 year)
Categories
10x Genomics (TXG) - Net assets
Net assets on the balance sheet as of December 2023 : $0.74 B
According to 10x Genomics
's latest financial reports the company has $0.74 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
10x Genomics - Net assets on balance sheet (from 2018 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $0.74 B | -8.03% |
| 2022-12-31 | $0.80 B | -1.45% |
| 2021-12-31 | $0.81 B | 10.62% |
| 2020-12-31 | $0.73 B | 75.93% |
| 2019-12-31 | $0.42 B | -290.96% |
| 2018-12-31 | $-0.22 B | 95.53% |
| 2017-12-31 | $-0.12 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | $6.18 M | -99.17% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | $80.25 M | -89.17% | 🇬🇧 UK |
 Novavax NVAX | -$0.72 B | -196.75% | 🇺🇸 USA |
 Novocure
NVCR | $0.36 B | -51.08% | Jersey |